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Abstract
Although it has been known for 50 years that adenoviruses (Ads) interact with erythrocytes ex vivo, the molecular and
structural basis for this interaction, which has been serendipitously exploited for diagnostic tests, is unknown. In this study,
we characterized the interaction between erythrocytes and unrelated Ad serotypes, human 5 (HAd5) and 37 (HAd37), and
canine 2 (CAV-2). While these serotypes agglutinate human erythrocytes, they use different receptors, have different
tropisms and/or infect different species. Using molecular, biochemical, structural and transgenic animal-based analyses, we
found that the primary erythrocyte interaction domain for HAd37 is its sialic acid binding site, while CAV-2 binding depends
on at least three factors: electrostatic interactions, sialic acid binding and, unexpectedly, binding to the coxsackievirus and
adenovirus receptor (CAR) on human erythrocytes. We show that the presence of CAR on erythrocytes leads to prolonged in
vivo blood half-life and significantly reduced liver infection when a CAR-tropic Ad is injected intravenously. This study
provides i) a molecular and structural rationale for Ad–erythrocyte interactions, ii) a basis to improve vector-mediated gene
transfer and iii) a mechanism that may explain the biodistribution and pathogenic inconsistencies found between human
and animal models.
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Introduction
Adenoviruses (Ads) are nonenveloped double-stranded DNA
pathogens that infect all vertebrate classes. To date, all Ads display
a characteristic, icosahedral symmetry in which 240 subunits of
the trimeric hexon protein form the facets and 12 copies of the
penton, comprising the pentameric penton base protein and the
externally projecting trimeric fiber, form the vertices [1]. While
the stoichiometry of the penton base and hexon is apparently
conserved, the fiber can exist as a single or double copy at each
vertex [2]. At least in vitro and for most cell types, the fiber
mediates the initial attachment to primary receptors, such as the
D1 domain of the coxsackievirus and adenovirus receptor (CAR),
sialic acids, CD46, and others (for review see Zhang & Bergelson
[3]). Interaction with auxiliary receptor(s), in particular some of
the dimeric integrins via the Arg-Gly-Asp sequence (an integrin-
interacting motif) on the penton base, may induce internalization
of some serotypes. However, other auxiliary receptors or
mechanism of internalization may exist for human serotypes 40
and 41 (HAd40/41), and canine serotype 2 (CAV-2), which have
no identifiable integrin-interacting motif in the penton base [4,5].
Greater than 150 Ad serotypes have been isolated. Approxi-
mately 50 of these are currently classed as human pathogens that,
in most cases, generate subclinical ocular, respiratory and
gastrointestinal tract infections. In the immunocompromised host
however, lethal HAd infections can spread, via unknown
mechanisms, to the kidney, liver and brain [6,7]. The human
Ads (HAds) are divided into subgroups (or species or subgenera) A
- F. The triage of the human serotypes into subgroups is based in
part on serotype-specific ex vivo erythrocyte cross-linking (or
hemagglutination) [8]. The clinical hemagglutination assays use
lysates from virus-infected cells to crosslink erythrocytes from a
handful of species. This highly heterogeneous lysate contains
whole virus particles, empty capsids, penton monomers, penton
dodecahedrons, fiber monomers, hexon etc. By using fractionated
infected cell lysate, a handful of laboratories found that the
multivalent complexes containing fiber were responsible for
hemagglutination [9–12].
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and glycolipids. One of the most abundant glycoproteins on
erythrocytes is glycophorin A (,10
5 copies/cell). With its high
sialic acid content, glycophorin A is the main contributor to the
net negative cell-surface charge and is critical for minimizing cell–
cell interactions and preventing erythrocyte aggregation [13].
Sialic acid is a collective term for a family of 9-carbon
monosaccharides, which are often found as terminal sugar residues
on glycans of glycoproteins and glycolipids (usually a2-3, -6 or -8
linked). In addition to some HAds, a number of viruses, including
orthomyxoviruses, paramyxoviruses, picornaviruses, papovavirus-
es, coronaviruses, reoviruses and parvoviruses bind to sialic acids
[14–18]. Possibly because erythrocytes from different species vary
in their sialic acid content, the hemagglutination properties of
sialic acid-binding viruses may also diverge [19].
HAd subgroup D (serotypes 9, 15, 19p and 37) and B:2 (serotypes
11a, 11p and 34a) erythrocyte binding depends on the fiber head
and several attempts have been made to define the region(s)
responsible [20–23]. Among the HAds, serotype 37 is unusual: its
fiber head can bind CAR, CD46 and sialic acid, but the virus
appears to use only the latter two as functional receptors [24–26].
Burmeister et al. found that the sialic acid moiety bound to a basic
patch close to the center of the trimeric fiber heads of HAd37 and
HAd19p [27]. Interestingly, the putative hemagglutination domain
in subgroup D heads partially aligns with the sialyl-lactose binding
site, which on the basis of sequence alignments is likely to be
conserved in other members of this subgroup. These observations
raise the question as to whether Ad-erythrocyte interaction is a
consequence of fiber head-sialic acid interaction.
In this study we initially characterize the erythrocyte binding of
unrelated serotypes, HAd5, HAd37 and CAV-2. Although both
HAd37 and CAV-2 agglutinate human erythrocytes at low
particle-to-cell ratios, they use different receptors (sialic acid and
CD46 vs. CAR) [5,25,26], have different clinical tropisms (ocular
vs. respiratory tract) and infect different species. We found that
HAd37-erythrocyte interaction is primarily due to sialic acid
binding. We show by structural analysis that the CAV-2 fiber head
also contains a sialic acid binding site, but in contrast to HAd37
this site is modestly involved in hemagglutination. Unexpectedly,
our biochemical and competition analyses suggested that CAV-2-
erythrocyte interactions also depend on binding to CAR on
human and rat erythrocytes. Using a transgenic mouse that
expresses CAR on erythrocytes [28] we demonstrate that CAR-
binding Ads can be sequestered by CAR-expressing erythrocytes,
and prevent liver infection. Our study provides a molecular and
structural rationale for the 50-year-old enigma of ex vivo Ad-
erythrocyte interactions. In addition to the relevance for Ad
pathogenesis and vector biology, the expression of CAR by human
erythrocytes may shed light on the role of cell adhesion molecules
during erythropoiesis.
Results
Hemagglutination assays using Ads
Consistent with previous reports, we found that at a modest
physical particle (pp)-to-erythrocyte ratio (,130) HAd37 efficiently
agglutinates human erythrocytes (Figure 1A). When compared to
HAd37, CAV-2 hemagglutinates at ,20-fold lower ratio (i.e. more
efficiently, Figure 1B). In our hands, and consistent with others [29],
HAd5 also agglutinated human erythrocytes, but at a higher ratio
(.800 pp/erythrocyte) (Figure 1C). To assay the roles of HAd37
and CAV-2 capsid proteins, we incubated erythrocytes with
chimeric HAd5 vectors harboring the fiber from HAd37 [30] or
thefiber head from CAV-2 [31].We found that the HAd5-HAd37F
and HAd5-CAV-2H hybrid capsids induced agglutination at lower
ratios than HAd5 but not quite to those of HAd37 and CAV-2
(Figure 1D and E).Pre-incubatingerythrocytes with neuraminidase,
which removes sialic acid from their membranes, eliminated
agglutination by HAd37 and a HAd5-HAd37F hybrid capsid
(Figure 1, right hand column). In contrast, removing sialic acid from
erythrocyte membranes only modestly reduced CAV-2 and the
hybridHAd5-CAV-2Hagglutination (datasummarizedinTable1).
Together, these data suggest that the CAV-2 fiber head, like in
subgroup D and B:2 HAds, is responsible for hemagglutination
and that sialic acid binding plays a more significant role in HAd37
binding of human erythrocytes than it does for CAV-2.
To mimic the hemagglutination caused by HAd37 fiber head in
a virion-like context, we generated a multivalent protein complex
similar to the ‘‘complete hemagglutinin’’ described for HAd9 by
Norrby et al. [9]. For this purpose HAd3 penton dodecahedra
were incubated with chimeric ‘‘mini fibers’’ consisting of HAd3
fiber tail and shaft motifs 1+2 and HAd37 fiber head. In addition,
we generated HAd37 fiber heads containing mutations in the sialic
acid binding site [27] (see Table 2 for a list of fiber head mutants).
The HAd3 penton dodecahedra without a fiber did not cause
hemagglutination (data not shown). The dodecahedra containing a
wild type HAd37 fiber head (HAd37H
wt) (Figure S1) agglutinated
erythrocytes at low protein concentrations (about 10
4-fold less
mass than HAd37 virions) (Table 2). Similar to HAd37, this
‘‘complete hemagglutinin’’ poorly agglutinates neuraminidase-
treated erythrocytes (Table 2). The dodecahedra containing a
HAd37 fiber with a Lys to Glu mutation at amino acid 345 in the
sialic acid binding site (HAd37H
SA21), had at least a 10
5-fold
reduced hemagglutination activity compared to the dodecahedra
containing HAd37H
wt. The chimeric wild type CAV-2 fiber head
(CAV-2H
wt) did not bind to HAd3 penton dodecahedra, which
precluded equivalent experiments.
These data suggest that the HAd37 fiber shaft, hexon and pIX
do not play key roles during binding and that the sialic acid
binding site is involved in agglutination of human erythrocytes.
Binding of the fiber heads to erythrocytes and
glycophorin
To assay the binding of recombinant fiber heads, we incubated
HAd37H
wt and mutant fiber heads with erythrocytes and then
added anti-fiber head antibodies or antiserum. We then quantified
attachment by flow cytometry. HAd37H
wt (Figure 2A) and
Author Summary
In most cases, adenoviruses are thought to initially enter
the host via contact with epithelial cells and spread within
the host via an unknown mechanism. Most adenovirus
serotypes use a cell adhesion molecule dubbed ‘‘CAR’’ to
attach to cells. To assess, predict and understand
adenovirus biology and vectorology, many in vivo studies
use mice and monkeys. These animal models have been
considered reliable models in the realm of viral pathogen-
esis and gene transfer. One of the implications of our study
suggests that the rat may be a more appropriate model
during intravenous adenovirus delivery because like
humans, and unlike mice and monkeys, they also express
CAR on their erythrocytes. The identification of CAR on
human erythrocytes explains a 50-year-old enigma of
adenovirus hemagglutination, helps us better understand
adenovirus in vivo biology and may open new avenues to
understand the role of cell adhesion molecules during
erythropoiesis.
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(HAd37H
CAR21 and HAd37H
CAR22, mutation in Glu351 and
Ser299, data not shown) [24] bound to erythrocytes in a dose-
dependent manner. However, HAd37H
SA21 and HAd37H
SA22 (a
Tyr to Ala mutation at amino acid 312), which harbor mutations
in the sialic acid binding site, poorly bound erythrocytes
(Figure 2A). In addition, all of the HAd37 fiber heads poorly
bound neuraminidase-treated erythrocytes (Figure 2A, bottom row
and data not shown).
Together, these data suggest that the HAd37 fiber head sialic
acid binding site is a key determinant in the attachment to human
erythrocytes.
Using the above approach, we detected minimal binding of
CAV-2H
wt to erythrocytes (data not shown), possibly because the
affinity of single CAV-2 fiber heads is low, the high affinity
polyclonal antibody binding out-competed the weaker erythrocyte
binding, and/or the number of CAV-2 fiber head receptors on
erythrocytes is low. To address the potential competition, we
incubated fluorescently labeled CAV-2 fiber heads with erythro-
cytes to circumvent the use of antibodies. Here we detected low,
but reproducible, binding of CAV-2H
wt to mock-, as well as
neuraminidase-treated, erythrocytes (Figure 2B).
Together, these data suggest that CAV-2 erythrocyte binding is
notably less dependent on sialic acid than HAd37, and the lower
binding may be due to reduced affinity or fewer receptors.
To address sialic acid-fiber head interaction using a cell-free
system, glycophorin or asialoglycophorin (asialoGP) were immo-
bilized on BIAcore sensor chips and increasing concentrations of
HAd37 fiber heads were assayed. All binding curves had a square
shape, suggesting high on and off rates (Figure S2). HAd37H
wt
bound to glycophorin, but less efficiently to asialoGP. Compared
to HAd37H
wt, HAd37H
SA22 bound equally to asialoGP, but less
to glycophorin. Interestingly, HAd37H
SA21 (Lys345Glu) bound
less efficiently to glycophorin and asialoGP compared to
HAd37H
wt and HAd37H
SA22, which suggests that HAd37
agglutination may be charge-dependent.
Consistent with the erythrocyte binding data, we found very
little binding between CAV-2H
wt and glycophorin or asialoGP
(data not shown). Overall, the SPR results reflect the results
Figure 1. Hemagglutination assays with HAd37, CAV-2, HAd5 or hybrid capsids. Mock-treated (left hand column) or neuraminidase-
treated (right hand column) erythrocytes (all wells contain the same number of cells) were incubated with serial dilutions (10-fold vertically and 2-fold
horizontally) of A. HAd37; B. CAV-2; C. HAd5; D. HAd5-HAd37F, a hybrid capsid containing the HAd37 fiber on the HAd5 capsid; and E. HAd5-CAV-
2H, a hybrid capsid containing the CAV-2 fiber head on the HAd5 capsid. Agglutination is visualized by the lack of erythrocyte sedimentation (no red
spot) at the bottom of the conical well (see Figure S4 for graphic description). The pink shaded well is the first well that does not significantly
agglutinate. All assays were performed at least three times.
doi:10.1371/journal.ppat.1000277.g001
Table 1. Virus-induced hemagglutination
Hemagglutinin
Mock-
treated
Neuraminidase-
treated
CAV-2 7 20
HAd37 130 ‘
HAd5 700 600
HAd5-CAV-2H 33 200
HAd5-HAd37F 200 ‘
CAV-2 (GATA1-CAR erythrocytes) 10 10
The agglutination titer in physical particles-to-erythrocyte (1.5610
6
erythrocytes/well).
High numbers=poor agglutinator.
‘=no agglutination
doi:10.1371/journal.ppat.1000277.t001
CAR and Sialic Acids on Human RBCs
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treated erythrocytes.
Structural analysis of the CAV-2 fiber head suggests a
sialic acid binding site
Our results suggested that HAd37 hemagglutination was due to
sialic acid binding via the sialic acid binding site in the fiber head.
Although we have no evidence suggesting that CAV-2 can use sialic
acid as a functional receptor, it is possible that the efficient CAV-2
agglutination of human erythrocytes is due to multiple and
coordinated binding of sialic acid. For example, each of the 12
homotrimeric fiber heads on the end of the flexible CAV-2 shaft [32]
could bind three sialic acid moieties (theoretically up to 36/capsid).
Because the predicted subgroup D fiber head hemagglutination
domains (in the CD and GH loops) appear to be well conserved, we
tried to identify the corresponding domain in the CAV-2 fiber head
using a mutagenesis strategy based on sequence homology (Figure
S3). This approach was unsuccessful (data not shown), suggesting that
Ad hemagglutination sites are not strictly conserved.
To address possible sialic acid binding via an alternative
approach, we soaked CAV-2 fiber head crystals in solutions
containing 2-3 sialyl-D-lactose. The crystal diffracted to 1.9 A ˚ and
the structure was solved by molecular replacement using our
model of CAV-2 fiber head [24] (crystallographic details are
summarized in Table S1). The electron density maps showed clear
density for six N-acetyl neuraminic acid (Neu5AC) moieties in the
asymmetric unit, three per fiber head trimer. Sialyl-lactose is
composed of three sugar rings, the sialic acid moiety being linked
to lactose (galactose-glucose). The density for the lactose moieties
was weak, implying that these are flexible within the crystal. Only
one of the six galactose rings in the asymmetric unit could be
modeled. This molecule is located in between the two fiber head
trimers in the asymmetric unit and forms a distant hydrogen bond
(distance 3.25 A ˚) to Lys503 via the galactose oxygen 6. It is
unlikely that this interaction is enough to immobilize the galactose
ring because the other five galactose moieties in the asymmetric
unit are not equally well visible in the electron density. More likely,
the stabilization is due to the spatial restrictions imposed by the
proximity of the other fiber head trimer.
We found that the sialic acid binding site on CAV-2 head is
distinct, both in sequence and location, from that found on the
HAd37 fiber head. On the CAV-2 fibers head, sialic acid binds
further away from the three-fold symmetry axis at the periphery of
the trimer (Figure 3A–D). The residues involved in binding
(Asn435, Ser419, Ser416, Gln417 and Arg515) do not align with
those involved in sialic acid-binding by HAd37 fiber head (Figure
S2). The HAd37 sialic acid binding site consists of three residues
forming hydrogen bonds (Tyr213, Pro317 and Lys345) and two
residues contacting sialic acid in hydrophobic interactions (Tyr308
and Val322) (Figure 3E). All seven interactions between CAV-2
fiber head and sialic acid are hydrogen bonds or salt bridges
(Figure 3F), suggesting a relatively strong interaction compared to
HAd37. Unlike HAd37 fiber head [33], no hydrophobic contacts
contribute to sialic acid binding. Finally, sialic acid binds within a
basic patch in each head (Figure 3C and D).
CAV-2 and HAd37 fiber heads bind CAR and sialic acid
simultaneously
Our results showing that the CAV-2 fiber head contains a sialic
acid binding site creates a paradox: both HAd37 and CAV-2 fiber
heads contain CAR and sialic acid binding sites - but HAd37 uses
sialic acid and CD46, while CAV-2 uses CAR (CAV-2 does not
use CD46 to infect cells, unpublished data) to infect cells. To
determine if sialic acid and CAR binding were mutually exclusive,
we soaked CAV-2 or HAd37 fiber head crystals in complex with
CAR in solutions containing sialyl-D-lactose. Crystals containing
the complex with CAV-2 fiber head diffracted to 2.9 A ˚ and
contained 12 chains of fiber head bound to 12 chains of CAR D1
and 12 sialyl-D-lactose molecules in the asymmetric unit (space
group I422). Crystals containing the complex with HAd37 fiber
Table 2. Relative hemagglutination titers of capsid subunits (higher numbers=poor agglutinator)
HAd3 dodecahedra ‘‘
HAd3 dodecahedra with mini HAd37 head 10 1610
6
HAd3 dodecahedra with mini HAd37H
SA21 1610
6 ‘
HAd37H
wt: wild type HAd37 fiber head 10 ‘
HAd37H
SA21: HAd37 fiber head with K345E mutation ‘‘
HAd37H
SA22: HAd37 fiber head with Y312A mutation ‘‘
HAd37H
CAR21: HAd37 fiber head with E351A mutation 10 ‘
HAd37H
CAR22: HAd37 fiber head with S299A mutation 10 ‘
CAV-2H
wt: wild type CAV-2 fiber head ‘‘
CAV-2H
SA21: CAV-2 fiber head mutant R515A ‘‘
CAV-2H
SA22: CAV-2H
SA21 with a N435A mutation ‘‘
CAV-2H
CAR2: CAV-2 fiber head with E384A mutation (CAR binding site) ‘‘
CAV-2H
wt: trimeric clusters 1 ‘
CAV-2H
SA21: trimeric clusters 1000 ‘
CAV-2H
SA22: trimeric clusters 1000 ‘
A relative comparison of protein concentrations that induced agglutination of human erythrocytes.
Higher numbers=poor agglutinator: Like sample (e.g. dodecahedra vs. dodecahedra, fiber heads vs. fiber heads, or trimeric clusters vs. trimeric clusters) can be
compare.
The highest concentration of HAd3 dodecahedra alone or in complex with mini-fibers was 3610
24 mg/ml.
The highest concentration of His-tagged CAV-2 fiber head constructs was 5610
24 mg/ml. a(2-3,-6,-8 and -9) neuraminidase was used in this assay.
‘=no agglutination.
doi:10.1371/journal.ppat.1000277.t002
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complex with one CAR D1 molecule and one sialyl-D-lactose
molecule in the asymmetric unit (space group I23). For both
structures the electron density maps showed clear density for sialic
acid, but not lactose, at the expected positions on the fiber heads
(Figure 3G and H).
Together, our data demonstrate that CAV-2 and HAd37 sialic
acid binding sites do not overlap with the CAR binding sites, and
both fiber heads can bind CAR and sialyl-D-lactose simultaneously.
CAV-2 fiber head-erythrocyte interactions may be
partially charge dependent
Arnberg and colleagues previously showed that HAd37
interaction with sialic acid was inhibited at high salt concentration
[33]. To determine if a CAV-2-erythrocyte interaction was at least
partially charge dependent, we incubated a CAV-2 vector
expressing GFP (CAVGFP) or a HAd5 vector expressing GFP
(AdGFP) with mock- or neuraminidase-treated erythrocytes in
PBS containing increasing concentrations of ions. We then
pelleted the erythrocytes by centrifugation, removed an aliquot
of the supernatant, added it to cells, and assayed the cells for GFP
expression by flow cytometry 24 hr post-infection. Using mock-
treated erythrocytes (Figure 4), we found that at physiological salt
concentrations ,80% of CAVGFP was removed from the
supernatant, while at higher salt concentration (300 mM NaCl)
,60% of CAVGFP was removed. When using neuraminidase-
treated erythrocytes, we again found that CAVGFP was efficiently
removed from the supernatant. All the test samples were
Figure 2. Binding of wild type and mutant fiber heads to human erythrocytes. A. HAd37 fiber head binding to erythrocytes (mock-treated,
top panels or neuraminidase-treated, bottom panels) as measured by flow cytometry. The shadowed profile=mock-treated erythrocytes without
fiber heads. The line graphs correspond to four 10-fold dilutions (13, 1.3, 0.13 and 0.013 mM) of three HAd37 fiber heads: HAd37
wt=wild type,
HAd37
SA21 and HAd37
SA22 contain mutations in the HAd37H sialic acid binding domain. The lowest dilution (0.013 mM=the dotted line in the top
left panel. The darkest line (furthest to the right in the top left panel)=13 mM. Except for the modest binding of 13 mM HAd37
SA22 to
neuraminidase-treated cells (bottom row middle panel), no other notable binding could be detected and therefore the line profiles overlap or are
hidden by the shadowed mock-treated profile. B. Fluorescently-labeled CAV-2 fiber head (CAV2H
wt) binding to mock-treated (left) or neuraminidase-
treated (right) erythrocytes as measured by flow cytometry. Three 10-fold dilutions of CAV2H
wt (13, 1.3 and 0.13 mM) covalently labeled with Cy5
were assayed. The shadowed profile=mock-treated erythrocytes without fiber heads. As above the highest concentration of fiber head is in the
darkest line profile. All assays were performed at least twice in triplicate.
doi:10.1371/journal.ppat.1000277.g002
CAR and Sialic Acids on Human RBCs
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the mock-treated 150 mM NaCl (P,0.05). Consistent with other
studies [29,34] AdGFP was also efficiently (90%) removed from
the supernatant after the incubation with mock- (or neuramini-
dase-) treated erythrocytes.
These data suggest that, like HAd37, a modest degree of CAV-
2-erythrocyte interactions may depend on electrostatic interac-
tions. In addition, both the CAR-tropic adenoviruses (HAd5 and
CAV-2) bind human erythrocytes at physiological salt concentra-
tions.
CAR expression by erythrocytes influences CAV-2
agglutination
While our results show that HAd37 hemagglutination is due
primarily to sialic acid binding, CAV-2 hemagglutination
appeared more complex. We therefore developed additional tests
to address the molecular and structural basis. Due its sensitive and
semi-quantitative potential, we returned to hemagglutination
assays to understand the erythrocyte interactions.
Freshly purified CAV-2H
wt, which predominantly consists of
individual trimeric fiber heads, did not cause hemagglutination,
presumably because it is not sufficiently multivalent to crosslink
erythrocytes. However, several His-tagged Ad fiber heads,
including those of HAd41 short fiber [35] and HAd37, form
multimers that dissociate into single trimeric fiber heads upon
removal of the histidine tag. Similarly, His-tagged CAV-2 fiber
head forms multimers of a defined size that are stable on a size-
exclusion column and can be visualized with an electron
microscope (not shown). Removal of the His-tag yields single
fiber heads. We found that His-tagged CAV-2H
wt agglutinated
erythrocytes, while His-tagged CAV-2H
SA21 and CAV-2H
SA22
(two CAV-2 fiber heads with one or two mutations in the sialic
acid binding site, see Table 2) showed reduced hemagglutination
titers. However, we could not exclude the possibility that the
reduced hemagglutination in these latter CAV-2H constructs was
due to electrostatic interactions (the mutations modified the charge
of the fiber heads).
We next assayed CAV-2 hemagglutination using a competition
assay (see Figure S4 for schema). In these competition assays, we
pre-incubated erythrocytes with fiber heads, antibodies, salt and/
or neuraminidase. Then the erythrocytes were incubated with
CAV-2 and compared to mock-treated erythrocytes. We found
that hemagglutination could be .256-fold reduced by pre-
incubating CAV-2 with anti-fiber head antibodies, or pre-
incubating erythrocytes with CAV-2H
wt (see Figure 5A for specific
example and 5B for cumulative data). Pre-incubating the
erythrocytes with the head from HAd5 or performing the assay
in 225 mM NaCl led to modest 2 to 4-fold reductions.
Unexpectedly, we found that like CAV-2H
wt, CAV-2H
SA21
notably reduced agglutination (,16-fold), while a CAV-2 fiber
head with a mutation in the CAR binding site (CAV-2H
CAR2)
had a modest ,2-fold reduction. In most cases, pre-treating
erythrocytes with neuraminidase had a fairly small additive effect
of CAV-2 hemagglutination.
Together, these data suggest that the CAR binding site, which is
present in CAV-2H
wt and CAV-2H
SA21 but not CAV-2H
CAR2,i s
involved in CAV-2 agglutination of human erythrocytes. That the
CAV-2 CAR binding site is involved in erythrocyte binding is
consistent with the study by Nicol et al. [36], which showed that a
CAR-ablated HAd5 vector no longer agglutinated human and rat
erythrocytes.
The presence of CAR on erythrocytes would be inconsistent
with other reports [34]. Among other functions, CAR acts as a
homodimeric cell adhesion molecule at tight gap junctions [37].
However, the expression of cell adhesion molecules during
erythropoiesis is not unprecedented [38]. Erythrocytes from some
species express cell adhesion molecules during the early stages of
differentiation that are thought to be involved in interaction with
macrophages. We therefore incubated erythrocytes with anti-CAR
antibodies that recognize the extracellular domain of CAR and
assayed expression using flow cytometry. We found low, but
reproducible, CAR expression on the cell surface of human
Figure 3. Structure of the CAV-2 fiber head in complex with
sialic acid and CAR. A. Ribbon diagram of CAV-2 fiber head in
complex with sialyl-D-lactose (red=Neu5AC, yellow=fiber head). B.
Cartoon representation of HAd37 fiber head in complex with sialyl-D-
lactose (red=sialic acid, blue=fiber head). C. Surface charge represen-
tation of CAV-2 fiber head and cartoon representation of sialic acid as
found in the complex. D. Surface charge representation of HAd37 fiber
head and cartoon representation of sialic acid as found in the complex.
E. Representation of the contacts between CAV-2 fiber head (purple)
and sialic acid (yellow). F. Representation of the contacts between
HAd37 fiber head (purple) and Neu5AC (yellow). G. Ribbon diagram of
CAV-2 fiber head in complex with CAR D1 and sialyl-D-lactose
(red=Neu5AC, green=CAR, yellow=fiber head). H. Ribbon diagram
of HAd37 fiber head in complex with CAR and sialyl-D-lactose
(red=Neu5AC, green=CAR, blue=fiber head).
doi:10.1371/journal.ppat.1000277.g003
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approach, we used western blot analysis to screen erythrocytes
from several species. Using an anti-CAR Ab that recognizes the
cytoplasmic domain of CAR we found CAR expression on human
and rat, but not on mouse, dog, rabbit and nonhuman primate
erythrocytes (Figure 6B and data not shown). Again, our results
showed a relatively low level of CAR on human erythrocytes,
which is consistent with the low level of CAV-2H
wt binding to
erythrocytes (Figure 2B).
These data suggest that CAR binding is a significant factor in
CAV-2, and likely other CAR-tropic Ads, interaction with human
erythrocytes. This also is consistent with the fact that CAV-2
agglutinates rat erythrocytes, but not erythrocytes from mice, dogs,
rabbits or some nonhuman primates (as well as other species)
(Figure S5).
If CAR binding plays a role in CAV-2 agglutination, then
knocking down/blocking or artificially expressing CAR on
erythrocytes should prevent/induce hemagglutination. Eliminat-
ing CAR on mature enucleated erythrocytes is technically
challenging. Furthermore, to the best of our knowledge there are
no known anti-CAR antibodies that completely block Ad
attachment. On the other hand, CAR has been expressed on
erythrocytes using a transgenic mouse line (GATA1-CAR) with
the CAR cDNA downstream of the globin transcription factor 1
promoter [28]. Using flow cytometry and western blot analysis
(Figure 6A & B), we compared the levels of human CAR expressed
by GATA1-CAR and human erythrocytes. We then repeated the
hemagglutination assays using erythrocytes from control (C57BL/
6) and GATA1-CAR mice. We also found that CAV-2
agglutinated GATA1-CAR erythrocytes at a low particle-to-cell
ratio (Figure 6C), while there was no agglutination of C57BL/6
erythrocytes. Equally important, competition assays with recom-
binant CAV-2 fiber heads gave profiles that were similar to when
we used human erythrocytes (Figure 6D, and data not shown).
Together, our data demonstrate that CAR expression by
erythrocytes can lead to agglutination by CAR-tropic adenoviruses.
The role of CAR in Ad biodistribution and pathogenesis
In spite of recent notable advances [39,40], in vivo Ad
biodistribution, tropism and pathogenesis for the CAR-tropic HAds
are still poorly understood. Group C HAd serotypes 2 and 5 are the
prototype Ads in terms of structure, tropism and pathogenesis.
However, tropism has been primarily studied in vitro, ex vivo or in
animal models. Our results showing that human and rat
erythrocytes harbor CAR on their external membranes while mice
and nonhuman primates do not, suggests that these latter animals
poorly mimic the in vivo environment that Ads encounter.
To better address in vivo biodistribution of CAR-tropic Ads, we
injected GATA1-CAR and control C57BL/6 mice with a HAd5
vector and quantified viral genome blood half-life and tissue
distribution. We found that the viral load in the blood was 1000-
fold higher (P,0.01) in GATA1-CAR versus isogenic control mice
(CAR-negative erythrocytes) during the first 72 hr post-injection
(Figure 7A). These data are reminiscent of the studies where
human blood cells are routinely positive by qPCR for wild type
HAd sequences [6,7]. In addition, notably absent from the
Figure 4. HAd5 and CAV-2 binding to human erythrocyte. CAVGFP or AdGFP was incubated with 2.5610
7 erythrocytes at 1 particle per cell
(equivalent to ,5610
9 pp in 1 ml of blood) in PBS and 6 additional NaCl. The erythrocytes were pelleted by slow speed centrifugation, and an
aliquot of the supernatant was removed and incubated with a monolayer of the most permissive and sensitive cells (911 cells for AdGFP and DKCre
cells for CAVGFP). These latter cells were analyzed for GFP expression by flow cytometry 24 hr post-incubation. The percent of GFP
+ cells versus the
control is shown for mock- or neuraminidase-treated erythrocytes. All samples are significantly (P,0.05) different from the controls. In addition, the
star (*) corresponds to a P value of ,0.01 between the mock-treated erythrocytes at physiologically relevant salt concentration (150 mM) and the
controls.
doi:10.1371/journal.ppat.1000277.g004
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the liver. Lack of transgene expression was also consistent with the
significant (P,0.01) ,25-fold difference in the mean viral load as
quantified by qPCR (Figure 7B). The lack of efficient liver
infection is also consistent with the generally unexpected and poor
infection of rat liver compared to mice and nonhuman primates
following injection of CAR-tropic Ad vectors.
Together, these data suggest that CAR expression by rat and
human erythrocytes plays a significant role in HAd in vivo distribution
and, in turn, determining which tissues are susceptible to infection.
Discussion
We initiated this study to examine a 50-year-old enigma of
adenovirus biology. Our results demonstrate that HAd37 interac-
tion with human erythrocytes is primarily due to sialic acid binding
viaa conservedsialicacid bindingsite onthissubgroup D HAdfiber
head. CAV-2, a serotype that like the prototype HAd5 is ‘‘CAR-
tropic’’ and by most criteria is unrelated to HAd37, interacts with
human erythrocytes via a mechanism depending on several factors,
including most notably binding to CAR.
Most subgroup D HAd sialic acid binding site residues are
conserved [27], and structural analysis suggest that they bind sialic
acid in an equivalent fashion. Unexpectedly, we found that the
CAV-2 fiber head harbors a sialic acid binding site. But, in
contrast to the well-conserved location of the CAR binding
domains on some Ad fiber heads, location of the sialic acid binding
site is not conserved.
Following the structure-based identification of the amino acids
in the CAV-2 and HAd37 fiber heads that interact with sialic acid,
Figure 5. CAV-2 hemagglutination assays using competition with fiber heads, 6 increased salt concentrations and 6
neuraminidase. A. Examples of the results from competition assay (see Figure S4 for the schema of the approach). The pink shaded well
corresponds to the last well that shows agglutination. A shift to the left of the pink shade signifies decreased agglutination due to blocking of the
virus binding site or removal of an attachment ligand. A 2-fold decrease in agglutination would correspond to a one-well shift to the left of the last
well that showed agglutination. Top control panel=agglutination of human erythrocytes by CAV-2 (for example ,8 pp/erythrocyte in the pink
shaded well on top row). Middle panel=erythrocytes preincubated with CAV-2H
SA21 (the CAV-2 fiber head that contains a mutation in the sialic acid
binding site but can still bind CAR) prior to the agglutination assay (,96 pp/erythrocyte in the pink shaded well, top row), which equals an ,8 to 16-
fold decrease from the control). Bottom panel=the same as the middle panel except that the erythrocytes were pretreated with neuraminidase (16
to 32-fold decrease). B. The graph shows the cumulative data from competition assays. CAV-2- agglutination of mock-treated erythrocytes was used
as the starting point. The blocking agent was used with mock (black bars) or neuraminidase-treated (grey bars) erythrocytes. All assays were
performed at least three times.
doi:10.1371/journal.ppat.1000277.g005
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acid binding and erythrocyte interaction. In a number of
conditions and approaches we showed that hemagglutination by
HAd37 depends primarily on sialic acid binding. First, removing
sialic acids from erythrocytes with neuraminidase eliminated
erythrocyte cross-linking by HAd37 and a chimeric capsid
harboring the HAd37 fiber head. Likewise, pre-incubation with
neuraminidase significantly reduced hemagglutination caused by
protein complexes containing multiple copies HAd37 fiber heads.
Second, mutating single residues in the sialic acid binding sites
reduced the hemagglutination activity of these protein complexes.
Third, wild type HAd37 fiber heads bound more efficiently to
erythrocytes or glycophorin than those carrying a point mutation
in the sialic acid binding site. Our binding assays using wild type
and mutated HAd37 heads also suggested that the sialic acid
affinity is partially charge-driven. In addition, although HAd37
head also binds CAR [24], in the context of the virus it does not
appear to use CAR as a receptor, possibly due to its relatively short
fiber. Therefore, CAR on erythrocytes is likely to be less important
for HAd37 biodistribution.
In spite of our structural data showing a well-defined sialic acid
binding site, we could not detect notable binding between CAV-2
fiber head and glycophorin, a highly sialated protein. It was
possible that the affinity of CAV-2 fiber head to erythrocytes or
glycophorin was lower than that of HAd37 fiber head, and that the
efficient erythrocyte binding of CAV-2 depended on the avidity of
Figure 7. Biodistribution of CAR-tropic HAd5 in GATA1-CAR mice. Mice were injected intravenously with an HAd5 vector expressing GFP
(AdGFP) and blood and livers were recovered at the indicated times and assayed for vector genomes and/or GFP expression. A. qPCR of viral
genomes in the blood at ,15 min (0.25 hr), 6 hr, and 1 and 3 days post-injection normalized by copies of GAPDH for each mouse (four GATA1-CAR
and four C57B/6 mice, the isogenic strain) (left hand panel) and the mean of each group (right hand panel). qPCR was performed twice in triplicate. B.
Histological section from the liver of representative mice at day 3 (72 hr). GFP expression from AdGFP is indicated by the green cells (white arrows).
The sections were stained with Hoechst to show the nuclei (in blue) and phalliodin-TRITC to show actin filaments (red, or yellow if an overlap with
GFP signal) (left-hand panel). qPCR analysis of the viral genomes in the livers of four GATA1-CAR and four C57BL/6 mice at day 3 (right hand panel).
qPCR was performed twice in triplicate.
doi:10.1371/journal.ppat.1000277.g007
Figure 6. CAR expression by erythrocytes leads to CAV-2 induced agglutination. A. Flow cytometry analysis of CAR expression by human,
mouse and GATA1-CAR mouse erythrocytes using the anti-CAR E1.1, which recognizes the native form of CAR. B. Western blot analysis of CAR
expression using the polyclonal anti-CAR antibody CAR1605, which recognizes the denatured form of CAR: murine fibroblast (NIH 3T3 cells, CAR
2),
human embryonic kidney cells (293 cells, CAR
+) and mouse liver (CAR
+), and human, rat, mouse (C57BL/6) and GATA1-CAR mouse erythrocytes. An
anti-actin staining was used to control the protein input. C. Hemagglutination assay using C57BL/6 and GATA1-CAR mouse erythrocytes. No
significant agglutination was found with C57BL/6 mice while GATA1-CAR erythrocytes agglutinated with ,3 pp of CAV-2/erythrocyte (pink shaded
wells). D. Hemagglutination competition assay using GATA-CAR erythrocytes and performed as described in Figure 5 using a higher concentration of
the fiber head (as would be expected due to the higher levels of CAR on GATA-CAR erythrocytes).
doi:10.1371/journal.ppat.1000277.g006
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HAd37 fiber head (pI’s of 8.4 and 9.2 respectively), this could have
explained the lower affinity. The affinity between virus proteins
and sialic acid is usually in the millimolar range; therefore it was
conceivable that the affinity of single CAV-2 fiber heads to
erythrocytes or glycophorin was low. Consistent with this
assumption, we previously found that CAV-2 is more neutrally
charged than other Ads [32]. Paradoxically though, CAV-2
agglutinates at a lower particle-to-cell ratio than HAd37 and our
crystallography data suggested that sialic acid binding should be at
least as strong as HAd37. However, one cannot reliably predict
affinity from structural data.
The identification of CAR expression by erythrocytes from
species that are agglutinated by CAR-tropic Ads is a crucial
observation. Using i) competition assays with recombinant fiber
heads harboring point mutations in the sialic acid and CAR
binding sites and ii) transgenic mice expressing CAR on
erythrocytes, we characterized the unexpected and significant role
of CAR in Ad binding.
As mentioned previously, Ad serotypes differ in their ability to
bind erythrocytes from various species. Our study suggests that this
may be due to i) an interaction with different chemical variants,
linkages and ratios of sialic acid, ii) the presence and affinity to
CAR, and/or iii) the pI’s of the head [33]. For example, some
non-CAR-tropic Ads that agglutinate human erythrocytes may
preferentially bind Neu5AC, the most abundant sialic acid on
human erythrocytes. With respect to charge, both HAd37 and
HAd19p bind sialic acid with equal affinity and the only two
residues that differ between their heads are not close to the sialic
acid-binding site [33]. With the limited amount of data available,
subgroup D HAds tend to have heads with higher pI’s and interact
with sialic acid [33]. Interestingly, the residues that make up the
CAV-2 sialic acid binding site are conserved in the CAV-1 fiber
head (data not shown), suggesting a conserved sialic acid binding
function. With respect to CAR affinity, the CAV-2 fiber head
binds human CAR with the highest affinity of any fiber head
known [24], which may favor its efficient hemagglutination. In
contrast to other Ads, higher temperatures poorly inhibit CAV-2
hemagglutination [12], again suggesting a role for the high-affinity
attachment to CAR. This is also consistent with a rather large
difference between HAd5 and CAV-2 hemagglutination: to the
best of our knowledge the HAd5 head does not harbor a sialic acid
binding site and its pI (6.25) is less basic than HAd37 or CAV-2.
Finally, we cannot exclude a role of the inter- and intra-species
differences in the quantity of CAR expressed by erythrocytes.
Phylogenetically, CAR expression by erythrocytes appears to be
random; we tested several other species (dogs, mice, rabbits,
lemurs and monkeys) and did not find CAR expression. However,
CAR levels on rat erythrocytes were relatively high (Figure 6) and
consistent with our hypothesis that CAR-tropic Ads agglutinates
human and rat erythrocytes via CAR binding. It is possible, but
unlikely, that our lack of detection of CAR on erythrocytes on
some species was due to the limit of sensitivity of our bank of anti-
CAR antibodies, which nonetheless detected CAR expression on
other cell types from these species (not shown). In the context of
the significant amount of HAd5-mediated gene transfer data, our
data highlights an important parallel. While a 30-gram mouse can
be injected intravenously with up to 10
12 pp of an HAd5 vector
with minimal side effects, injection of the same dose in a 250-gram
rat is normally lethal [41]. Whether our data have a bearing on the
death following portal vein injection of a HAd5 vector during a
phase I trial [42] is unknown, but deserves consideration.
Similar to the CAR binding domain in HAd37, we can only
speculate about the importance of sialic acid binding in the biology
of CAV-2. Although CAV-2 does not agglutinate dog erythrocytes
(Figure S4), Canis lupus familiaris may not be the original host of
CAV-2: seroprevalence against CAV-2 can be found in coyotes,
bears, pandas, skunks, mongooses, raccoons and foxes [43–45]. It
is paradoxical that HAd37 binds CD46, sialic acid and CAR - yet
does not use CAR [25] - while CAV-2 binds both sialic acid and
CAR and to the best of our knowledge uses only CAR as a
receptor [5]. We cannot exclude the possibility that in some cell
types sialic acid binding provides a first low-affinity attachment to
the cell surface, while CAR-binding is followed in a second step,
providing a high-affinity binding. Similar two-step mechanisms
have been proposed for other viruses [46]. It is tempting to
speculate that sialic acid binding may play a role in the preferential
transduction of neurons by CAV-2 vectors [47–50]. Our crystal
structure of CAV-2 fiber head in complex with CAR and sialyl-D-
lactose demonstrates that the ternary complex of the three
molecules is stable. There is no indication that this should not
be the case also in vivo.
Our data and numerous reports describing the ex vivo interaction
of CAR-binding HAd5 with human/rat erythrocytes [12,21–
23,29,36,51–53] strongly suggest this interaction probably occurs
after the intravascular injection of CAR-tropic vectors. Notably,
Lyons et al. showed that that .90% HAd5 vector DNA was
associated with blood cells following intratumoral injection during
a clinical trial [34].
It is likely that erythrocyte binding occurs during wild type
infection of some HAds (as well as coxsackie B viruses) that use
CAR, which will certainly lead to altered biodistribution. HAd
DNA is routinely found in human blood cells by PCR. It is also a
common misconception that Ads are rapidly cleared following a
classical immune response. Numerous clinical cases strongly
suggest that latent HAds can readily resurface if the host is
immunosuppressed. The fate of particles that stick to erythrocytes
under natural or artificial (i.e. vector injections) conditions is
probably complex. For example, HAd5-induced liver disease in
immunocompromised humans is relatively common. In contrast,
immunocompromised nonhuman primates are rarely diagnosed
with simian Ad (SAV)-induced liver disease [54]. Does CAR
expression on erythrocytes lead to an advantage for host or virus?
Has CAR expression on erythrocytes put a selective pressure on
Ads (and coxsackie B viruses that also bind CAR) to avoid an
erythrocyte virus trap [28]? Or has CAR expression by
erythrocytes allowed HAds to thrive because it has allowed open
access to so many more tissues and cell types?
In summary, our results resolve a longstanding enigma of Ad-
erythrocyte interaction in vitro and in vivo. In addition, we provide
new insights into virus-erythrocyte interactions that will allow us to
better understand HAd pathogenesis and facilitate the engineering
of safer, more efficient gene transfer vectors. Although in most in
vivo scenarios hemagglutination per se is unlikely to occur due to the
turbulence that erythrocytes encounter in the circulation,
sequestering of vector particles by erythrocytes must diminish
gene transfer efficacy. Interest in Ad biology is continually growing
due to the increasing incidence of HAd-induced morbidity and
mortality during immunosuppression [55,56], and because Ad-
derived vectors are the most commonly used vectors in gene
therapy clinical trials. The identification of fiber head mutants that
do not bind human erythrocytes may be of interest. Equally
important may be the need to screen fiber heads from other
serotypes for sialic acid and CAR binding domains. Combined
with HAd interactions with vitamin K-dependent coagulation
factors [39], our study adds another critical element in the
interaction with blood components, biodistribution and patho-
genesis.
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Viruses, vectors and antibodies
CAV-2 (CAVGFP), HAd5 (AdGFP), HAd37, and the hybrid
HAd5-CAV-2H (Ad5Luc1-CK) and HAd5-HAd37F (Ad37f) vectors
were prepared as previously described [30,31,57,58]. Briefly,
CAVGFP and AdGFP are E1-deleted vectors expressing GFP. The
capsids contain no modifications. The hybrid HAd5-CAV-2H vector
contains the fiber head of CAV-2 on the HAd5 capsid. HAd5-
HAd37F vector contains the HAd37 fiber (shaft and head) on the
HAd5 capsid. All vectors were purified by double banding on CsCl
gradients,CsCl was removed using PD-10 columns (Pharmacia).The
vectors were stored in phosphate-buffered saline (PBS) containing
10% glycerol at 280uC. Stock titers were .1610
12 physical
particles/ml with .1 infectious particle/5 physical particles. Anti-
CAR antibodies tested in this study included E1.1 a monoclonal
mouse(S.Hemmi,University of Zurich),CAR1605 polyclonal rabbit
(J. Zabner), MoAbE(mh)1 monoclonal mouse (S. Carson, University
of Nebraska), and AF2654 (anti-mouse) and AF3336 (anti-human)
polyclonal goat (R & D Systems).
Negative staining
The recombinant fiber heads and dodecahedral sample were
loaded between the mica-carbon interface as described [59]. The
samples were stained using 2% sodium silico tungstate pH 7.5 and
air-dried. Images were taken under low-dose conditions in an
EX1200-II JEOL electron microscope working at 100 kV and
with a nominal magnification of 40,000. The images were scanned
on a Z/I Imaging scanner (Photoscan TD) with a pixel size of
14 mm (3.5 A ˚ per pixel at the sample level).
Generation of recombinant fiber head and labeling with
fluorophores
Fiber head constructs were cloned into pPROEX HTb (Life
Technologies) and expressed with a cleavable His-tag as described
previously [24]. HAd37 fiber head constructs contain residues 177–
365 and CAV-2 fiber head constructs contain residues 358–542.
Point mutations were introduced using the QuikChange Site-
Directed MutagenesisKit (Stratagene)and polymerasechainreaction
(PCR). Protein purification was performed as described [24]. Briefly,
cells were incubated in lysis buffer (20 mM Tris-HCl pH 7.5,
300 mM NaCl, 20 mM imidazole, (Boehringer Complete EDTA-
free protease inhibitor cocktail), centrifuged, and fiber head bound to
a Ni-NTA column(Qiagen). Eluted protein was either directly loaded
onto a Superdex200 column for hemagglutination experiments with
tagged fiber head, or incubated overnight with 1/100 His-tagged
tobacco etch virus (TEV) protease at 10uC. Proteins were then
dialyzed against lysis buffer and uncleaved protein and TEV protease
bound to a Ni-NTA resin. Untagged fiber head was loaded onto a
Superdex200 column using the same buffer as for tagged protein
(20 mM Tris pH7.5 and 300 mM NaCl). CAV-2H
CAR2 was labeled
using Alexa488 Microscale Protein Labeling Kit (Molecular Probes).
CAV-2H
wt was dialyzed in PBS 0.1 M NaCO3 pH 9.3 and labeled
using mono-reactive dyes (Cy3, Cy5 or Alex488, Amersham
Bioscience) for 45 min at room temperature. The elution of labeled
protein was performed with 2 ml of PBS using NAP5 column (GE
Healthcare) pre-equilibrated with 10 ml PBS. The final dye/protein
ratios (,2.4 for each) were determined using NanoDrop ND-100
spectrophotometer.
Crystallization of CAV-2 fiber head in complex with sialyl-
lactose
Untagged CAV-2 fiber head was concentrated to 17 mg/ml in
crystallization buffer (150 mM NaCl, 20 mM Tris pH 7.5, 8 mM
sialyl-D-lactose) and crystallized in hanging drops containing 1 ml
protein solution and 1 ml well solution (5% PEG 4000, 5%
isopropanol, 0.1 M HEPES pH 7.4). Single crystals were
transferred and frozen in a cryoprotectant solution (65% well
solution, 25% glycerol, approximately 80 mM sialyl-D-lactose).
The sialyl-D-lactose (Sigma) corresponds to a2-3 N-acetylneur-
aminosyl-D-lactose (according to the supplier).
Purification and crystallization of fiber head complexes
containing CAR D1 and sialyl-D-lactose
The cloning, expression and crystallization of HAd37 and
CAV-2 fiber head CAR D1 complexes (space groups I23 and
I422) was performed as described previously [24]. After crystal
growth, sialyl-D-lactose (Sigma) was added to the drop to a final
concentration of 10 to 50 mM. Crystals were frozen the next day
without adding cryoprotectant solution to crystals with CAV-2
fiber head complex, and with 20% glycerol in the crystallization
condition for crystals with HAd37 fiber head complex.
Data collection and processing
Details of the data collection and refinement of the three
structures (CAV-2+sialyl-lactose, CAV-2+CAR D1+sialyl-lactose
and HAd37+CAR D1+sialyl-lactose) are given in Table S1. All
crystallographic data were collected at the European Synchrotron
Radiation Facility (ESRF) and processed with XDS [60]. All
structures were solved by molecular replacement using PHASER
[61] and refined with REFMAC [62]. COOT [63] was used for
the visualization of all models and electron density maps, and for
the superposition of different models. PROCHECK [64] and
MolProbity [65] were used for the validation of the obtained
models. Representations of the protein models and the electron
density were made with PYMOL [66] and GRASP [67]. Binding
interfaces were visualized with DIMPLOT [68]. The structure-
based sequence alignment was made with SARF, modified
manually in SEAVIEW [69] and visualized with ESPript [70].
The CAV-2+sialyl-lactose structure contains two fiber head
trimers in the asymmetric unit. The CAV-2+CAR D1+sialyl-
lactose contains four trimeric fiber head - CAR D1 complexes in
the asymmetric unit. Due to the modest resolution of this
structure, NCS restraints and TLS refinement was used. The
HAd37+CAR D1+sialyl-lactose structure has one fiber head
monomer with bound CAR D1 in the asymmetric unit.
Cloning and purification of HAd3 penton dodecahedra in
complex with chimeric mini-fibers
Chimeric mini-fiber constructs were cloned by PCR in two steps.
First, DNA fragments were produced using as template HAd3
genomic DNA (for fragment 1) or pPROEX HTb vectors coding for
wild type or mutant HAd37 fiber head (for fragments 2 and 3).
Fragment 1 coded for HAd3 tail and shaftmotives 1+2 (primers were
AAT AAT CCA TGG CCA AGC GAG CTC GG and GTT CCA
TGC TAC CAA GGA TCC ATC AGT AG). Fragments 2 and 3
coded for wild type and mutant (K345E) HAd37 fiber head (primers
used were CTA CTG ATG GAT CCT TGG TAG CAT GGA AC
and AAT AAT GAA TTC TCA TTC TTG GGC AAT ATA GG).
In a second PCR reaction, fragment 1 was annealed to fragment 2 or
3 using primers AAT AAT GAA TTC TCA TTC TTG GGC AAT
ATA GG and AAT AAT CCA TGG CCA AGC GAG CTC GG.
The resulting longer fragments coded for complete mini-fiber
containing HAd3 tail+shaft and either wild type or mutant
(K345E) HAd37 fiber head. These were cloned into pPROEX
HTb, and expressed at 25uC in E. coli strain BL21 Star (DE3) (Life
Technologies) together with an N-terminal cleavable 66His-tag.
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was centrifuged for 30 min at 25000g and the supernatant loaded on
a Ni-NTA column (Qiagen). Protein bound to the resin was washed
with 20 mM Tris-HCl pH 7.5, 300 mM NaCl, 50 mM imidazole
and eluted in 20 mM Tris-HCl pH 7.5, 150 mM NaCl, 500 mM
imidazole. To remove the His-tag, mini-fibers were incubated
overnight with 1/100 His-tagged TEV protease at 10uC. Imidazole
was removed by dialysis against lysis buffer. Uncleaved protein and
TEV protease were removed by binding to a Ni-NTA resin. HAd3
penton forms multimers (dodecahedra) consisting of twelve penton
bases each [9,71]. P. Fender (Institut de Biologie Structurale,
Grenoble) generously supplied purified HAd3 dodecahedra. Mini-
fibers and dodecahedra were mixed at an approximate molecular
ratio of 1:10 and incubated at 4uC overnight. The mixture was
loaded onto a Superdex200 column (Amersham) to remove excess
fiber. The buffer contained 20 mM Tris pH7.5 and 300 mM NaCl.
Dodecahedra in complex with mini-fiber were eluted with the void
volume and were visualized with an electron microscope. All mini-
fiber constructs carrying HAd3 tail+s h a f ta n daC A V - 2f i b e rh e a d
were unstable, possibly because they were misfolded, or they did not
bind to HAd3 dodecahedra.
Flow cytometry
Non-treated, mock-treated or neuraminidase-treated erythro-
cytes and non-tagged fiber heads were incubated for 20 min at
4uC. Cell samples serving as negative control were incubated with
PBS instead of fiber head solution. The cells were pelleted at 800g,
re-suspended in PBS containing 1:100 rabbit anti-HAd37 fiber
head serum (gift from N. Arnberg, University of Umea ˚) or 1:100
purified rabbit antibodies against CAV-2 fiber head, and
incubated for 20 min at 4uC. The cells were pelleted as before,
re-suspended in PBS containing 1:100 anti-rabbit FITC labeled
antibody (Sigma) and incubated in the dark at 4uC for 20 min.
The cells were pelleted again, re-suspended in PBS, and injected
into a FACSCalibur apparatus (BD Biosciences). The results were
analyzed using CellQuest and FlowJo software (BD Biosciences).
Hemagglutination assays
Human, rat (Wistar), dog (beagle), vervet (Chlorocebus
pygerythrus), cynomologous monkey, rhesus macaque, guinea pig,
rabbit (New Zealand White), mouse (C57BL/6) or GATA1-CAR
[28] mouse blood was collected in EDTA, heparin or Alsever’s
solution. Erythrocytes were purified using Ficol gradients, washed
twice in PBS EDTA (5 min at 2000 rpm) and stored less than 48
hrs in PBS containing 5 mM EDTA. For the human and GATA1-
CAR mouse erythrocytes two fractions of packed erythrocytes
were re-suspended separately in neuraminidase buffer each.
Neuraminidase a(2-3,-6,-8 and-9) from Arthrobacter ureafaciens
(Sigma) or a(2-3,-6 and -8) (Ozyme) was activated as recommend-
ed, and added to one of the two erythrocytes fractions. Both mock-
(without neuraminidase) and neuraminidase-containing fractions
were incubated for 1 hr at 37uC. The cells were then washed 5
times with PBS to remove neuraminidase and buffer, and re-
suspended in PBS containing 5 mM EDTA. Virus, dodecahedra
6 chimeric mini-fibers and CAV-2 fiber head multimers were
diluted with PBS in 10-fold (in the first column) and then 2-fold
(horizontal) steps and added to 96-well plates with cone-shaped
bottoms. An equal number of purified erythrocytes (either non-
treated, neuraminidase-treated, or mock-treated) was added to
each well and incubated at room temperature or 37uC for at least
3 hrs. The blocking protein (,1 mg/well) was incubated with
erythrocytes for 1 h at 4uC with slow rotation. All assays were
repeated at least 3 times.
Sedimentation with erythrocytes
In a volume of 100 ml, CAVGFP or AdGFP (1 particle/cell) was
incubated with 2.5610
7 mock-treated or with neuraminidase-
treated erythrocytes with PBS, or PBS supplemented with NaCl to
bring its final concentration to 225 or 400 mM. The samples were
incubated at room temperature for 15 min, and then centrifuged
for 5 min at 5000 rpm in a microfuge. Aliquots of the supernatant
were removed and incubated with 1610
5 cells in 12-well plates.
The cells were trypsinized and assayed for GFP expression by flow
cytometry 24 hrs post-incubation. Data were analyzed using
CellQuest. The assays were performed twice and in quadruplicate.
Western blot
Control cells and tissues were lysed with 100 ml SDS buffer (10
6
cells) and benzonase for 1 h at 37uC. The liver, peripheral blood
mononuclear cells, NIH 3T3 cells (mouse fibroblasts) and 293 cell
(human embryonic kidney) extracts (40 mg/ml) were resuspended
in 100 ml of SDS-sample buffer. Erythrocytes (,200 ml) were lysed
in ddH2O, the membranes were pellet for 10 min at 14,000 RPM
in a microfuge and resuspended in 100 ml of SDS-sample buffer.
SDS-PAGE was performed using a 5% acrylamide/bis-acrylamide
stacking gel and a 12% acrylamide/bis-acrylamide running gel.
Membranes were blocked with TBS-Tween, 10% milk at room
temperature. The rabbit anti-CAR antibody CAR1605 was
diluted 2000-fold for 1 h at RT in TBS-Tween 10% milk. The
secondary anti-rabbit antibody was used at a dilution of 1/5000
for 30 min at room temperature in TBS-Tween 10% milk.
In vivo injection of Ad vector
Four adult GATA1-CAR and four control C57BL/6 mice were
injected with 1.2610
11 pp of AdGFP via the tail vein. Blood
(,100 ml) was taken by tail vein bleeds at 0.25, 6, 24 and 72 hr.
The mice were sacrificed at 72 hr by lethal injection, and the
organs were perfused with PBS via cardiac puncture. The liver,
lung and spleen were recovered, divided into parts for qPCR or
histology. The organs used for histology were fixed in 4% PFA for
24 hr then placed in 20% sucrose for 24 hr, and embedded in
OCT matrix (CellPath, Powys, UK). Sections (10-mm-thick) were
stained with 0.2 mg/ml bisBenzimide Hoechst (Sigma-Aldrich) and
1 ng/ml phalloidin-TRITC (Sigma-Aldrich) before being mount-
ed. Images were acquired using a Zeiss microscope and processes
using the MetaMorph (Molecular Devices, Wokingham, UK).
Ethics
The experimental protocols involving animals were approved
by the University of Massachusetts Medical School Institutional
Animal Care and Use Committee.
Quantitative PCR
Total DNA from blood and liver were extracted by using the
High Pure DNA Isolation kit (Roche Diagnostics). qPCR was
performed with a Light Cycler (Roche Diagnostics) using the
Platinum Taq DNA polymerase (Invitrogen) and SYBR Green
qPCR master mix [72]. The primer pairs used for GAPDH were:
GAPDH forward, 59 ACA GTC CAT GCC ATC ACT GCC 39;
GAPDH reverse, 59 GCC TGC TTC ACC ACC TTC TTG 39;
and the EGFP: forward, 59 CAG AAG AAC GGC ATC AAG GT
39; eGFP reverse, 59 CTG GGT GCT CAG GTA GTG G 39.
Data are expressed as a ratio of GAPDH to EGFP.
Statistical analysis
Data were analyzed using a one-way ANOVA and post-hoc
comparisons were made using an unpaired Student’s t-test.
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Figure S1 Electron micrographs of dodecahedra 6 fiber. A)
Ad3 penton dodecahedra B) Ad3 penton dodecahedra in complex
with chimeric minifiber containing wild type HAd37 fiber head.
To the right of the photos are computer generated models of the
structures. Below are enlarged images of the dodecahedra 6 fiber.
Found at: doi:10.1371/journal.ppat.1000277.s001 (1.11 MB TIF)
Figure S2 Binding of wild type and mutant fiber heads to
human erythrocytes. A) SPR curves obtained with different
concentrations of wild type HAd37 fiber head (HAd37Hwt) and
immobilized glycophorin (GP). B) SPR curves obtained with
HAd37Hwt and mutant HAd37 fiber heads (HAd37HSA-1 and
HAd37HSA-2) at 2 mM and immobilized GP. C) SPR curves
obtained with HAd37Hwt and mutant HAd37 fiber heads at 2
mM and immobilized asialoGP.
Found at: doi:10.1371/journal.ppat.1000277.s002 (0.27 MB TIF)
Figure S3 Sequence of the CAV-2 and HAd37 fiber heads.
Structure based sequence alignment of HAd37 and CAV-2 fiber
heads. Residues forming hydrogen bonds with sialic acid are
highlighted with a blue background; residues involved in
hydrophobic contacts with sialic acid are highlighted with yellow
background; residues providing both types of contacts are
highlighted in blue and yellow.
Found at: doi:10.1371/journal.ppat.1000277.s003 (0.99 MB TIF)
Figure S4 Flow chart showing competition-based agglutination
assays.
Found at: doi:10.1371/journal.ppat.1000277.s004 (1.87 MB TIF)
Figure S5 Relative agglutination with erythrocytes from differ-
ent species.
Found at: doi:10.1371/journal.ppat.1000277.s005 (0.10 MB TIF)
Table S1 Summary of data collection and refinement statistics.
Found at: doi:10.1371/journal.ppat.1000277.s006 (0.09 MB
DOC)
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